• Patients can undergo PEG-J placement as either an inpatient or outpatient. Either the inpatient setting or outpatient setting with a 23-hour observation period allays the concerns of patients and caregivers who are uncomfortable dealing with post-procedure symptoms without direct health supervision and input. The inpatient stay or observational period is an ideal time to educate patients and care partners about tube and stoma care.
• There is limited experience with approaches other than gastrostomy. Some clinicians have had success using transabdominal gastrojejunostomy and placement of 14-Fr Shetty tubing. Anecdotal evidence suggests the potential for less medication use, shorter procedure times, reduced costs, less pain, and fewer complications with 14-Fr Shetty tubing placement. It is important to note that this procedure has not been vetted in comparison with PEG-J placement and that the majority of clinical evidence and experience with LCIG has used the PEG-J system. There has also been 1 published report of LCIG delivery through a transcutaneous port (T-Port ® ) system. 31 The authors note that the number of device-related adverse events that occurred in their small patient cohort (N = 24) was lower than that of endoscopic gastrojejunostomy in the published literature; however, 1 infection and 14 stoma inflammations requiring T-Port explantation occurred in this study.
• Larger-gauge tubing should be considered if feeding through the gastric port of the PEG-J system is planned. Clinical experience with feeding through the PEG-J is limited. It is possible that feeding may increase risk for tube migration or occlusion.
• Although pain is generally minimal, a pain management plan that includes transitions in care should be established by the multidisciplinary team.
• Patient post-operative instructions for care of the stoma and tube should be provided both in discussion with a multidisciplinary team member and in written form. Discharge instructions should include standardized text for stoma care and medication dosing and be supplemented with patient-specific instructions for concomitant medications.
• US patients have the option to sign up for DuoConnect, which provides a contact point for questions regarding access and issues with the delivery system. DuoConnect is the AbbVie-sponsored program that provides assistance to HCPs and patients during the onboarding process, including nurse phone support and (optional) home nurse visits to reinforce patient and care partner education regarding stoma and tubing care, pump setup, etc. Three visits are typically scheduled: before the PEG-J placement, 24 hours after discharge, and on the day after titration initiation.
